SUMMARY Evidence is presented that a single injection of bacterial antigen in oil into a footpad of rats of 5 strains induced different clinical forms of adjuvant disease in the individual rat strains.
tinguished from disease severity, so that it is difficult to assess the significance of such observations.' 9-"" During initial studies with the SK Wistar rat we noticed that some reproducible features of adjuvant disease differed from those described previously. Accordingly we set out to compare features of the disease in SK rats with those developing in 4 other strains by recording them objectively on skeletal charts. In this paper we describe the method of recording, demonstrate how the data obtained are analysed to identify and quantify clinical features of adjuvant disease, show how clinical features may be distinguished from manifestations of disease severity, and how the data provide evidence that each strain of rat develops a different clinical form of adjuvant disease. We suggest that the particular form of inflammatory rheumatic disease developing in each rat as a consequence of the injection of mycobacteria in oil is genetically determined and that histocompatibility antigens of the rat interact with certain antigens of mycobacteria in some way to induce such disease. Materials strain, however, the first day on which inflammatory lesions appeared in any rat, the mean rate of dissemination of inflammatory lesions, and the incidence and characteristics of clinical features were reproducible; some features occurred only in one strain. Table 1 lists reproducible physical and clinical features of adjuvant disease in each strain of rat. It is seen that not all rats of the AHN and SH strains developed adjuvant disease and that the minimum latent interval varied with the strain. The ear lesions characteristic of adjuvant disease (erythematous nodule, papule, or blister-like lesion) did not occur regularly in rats of the AHN and SH strains; instead the AHN rats developed erythematous papules only, and in a few SH rats small nodules developed. In Tuck, AHR, and SH rats joint involvement showed a characteristic and specific pattern. In Tuck rats all joints were inflamed, but spinal involvement was prominent, and a kyphoscoliosis had developed by day 14. By contrast in AHR rats the spine and hips remained mobile despite intense inflammation of other limb joints. In SH rats wrist inflammation was prominent and was frequently the only site of inflammation. Many of the SH rats developed large granulomas of the wrists and injected foot that increased in size continuously until they were killed.
Of particular interest was the minimum latent interval which differed widely between the strains and was independent of the time to reach maximum joint score. Thus in AHR rats the minimum latent interval was only 6 days, while the time to reach maximum joint score in this strain exceeded that of the SK, Tuck, and AHN strains. Tuck rats developed gross lymphoid enlargement early, but in AHR rats splenic enlargment and minimal lymph node hypertrophy occurred late. The most characteristic strain-specific feature was the vasculitis of the tail developing in 15%SY of SK rats (Fig. 2) . This was manifest as a purpuric rash between days 28 and 34 on the distal third of the tail, which may subsequently become gangrenous. We have never seen vasculitis of the tail in any rat of another strain despite regular observation up to day 42, with many longer periods of observation up to 1 year.
The rate at which inflammatory lesions appeared in each strain of rat is represented by the mean joint score at intervals after injection (Fig. 3 ). SK and Tuck (Fig. 4) . These were (a) day of onset of inflammatory lesions; (b) maximum joint score attained by day 21; (c) time of maximum joint score. All SK rats developed maximum joint score by day 21, and thus these were taken as 'standard' and other strains were compared with them, by x2 test (Figs. 4a and c) and Mann-Whitney U test (Fig. 4b) . Tuck rats developed lesions significantly earlier than SK rats ( Fig. 4a; p<0 l001 ) and AHN and AHR rats significantly later (p<005); Tuck rats attained a significantly higher joint score by day 21 ( Fig. 4b; p<0001 ) and AHN rats a significantly lower score (p<005), while rats of the AHR strain did not differ from SK rats in respect of the score attained (p>0-1). The time taken to attain maximum joint score was significantly shorter in Tuck rats ( Fig.  4c; p<0001 ), but significantly longer in AHN and AHR rats (p<005). Few SH rats (data not shown) developed joint lesions before day 21, and in none did the joint score exceed 24. Therefore it may be concluded that each of the 5 strains showed a distinctive pattern of development of inflammatory lesions or mode of onset of adjuvant disease. These findings are summarised in Table 2. No differences were detected between groups of the SK, AHN, and AHR rats that could be ascribed to differences between the two batches of Mycobacterium tuberculosis.
S SK (10) -Tuck ( 13 ) Fig. 3 (a) first day on which inflammatory lesions were recorded in each rat; (b) maximum score attained in each rat by day 21; (c) the day on which each rat attained maximum score. The variable and unpredictable course and severity of adjuvant disease in individual rats and between groups was confirmed by these data and is described and discussed separately.t2 However, the charts provided a means of comparing the general and mean characteristics of groups within and between the different strains and when the data was analysed in this way, evidence of reproducible characteristics was obtained. Some gross features occurred only in one strain-for example, the long latent interval and predominance of wrist inflammation in SH rats. Only reproducible features are described in this paper. When the characteristics were tabulated by strain as in Table 1 it was apparent that there were differences in the clinical form of adjuvant disease and that there was a reproducible combination of physical, qualitative, and quantitative features specific to each strain. There were also characteristic modes of progression and regression of joint inflammation and chronicity ( Fig. 3 ) and each strain was significantly different from all other strains in the mode of onset of the disease (Fig. 4 and Table 2 ). Therefore we suggest that we have demonstrated that the disease developing in response to the single injection of mycobacteria in oil is of a different clinical form in each strain of rat. In all the strains the chief manifestation was joint inflammation, but the precise joints affected by the inflammatory process and the associated clinical features varied with, but were specific to each strain. Thus a spectrum of inflammatory rheumatic disease seemed to occur across these 5 strains.
Questions arise, first, as to why this has not been described previously; secondly, as to the possible implications of these findings and whether they suggest aetiological or pathogenetic mechanisms of rheumatic disease in man. Different clinical forms of adjuvant disease have been described subjectively by Glenn et al., 10 Swingle et al., 9 and Perlik et al., 11 but none of these authors followed up the observation. Other methods of recording features of adjuvant disease have been described,4 13 14 but these were concerned primarily with disease severity and are subjective at least in part. Thus no objective method of recording features of the disease has been described previously, and without such methodology this The varying susceptibility might be explained similarly, but the absence of disease in some rats of the AHN and SH strains suggests more that the immune response to the injected organism may be modified in such animals. Adjuvant disease may be induced by selected strains of a wide variety of common environmental organisms, so that rats could well be exposed (and sensitised) to such organisms early in life. It is not known if such pre-exposure is necessary for the development of adjuvant disease, but it is suggested that major and minor histocompatibility antigens interact in some way with environmental organisms to manifest a particular clinical form of inflammatory rheumatic disease after injection of (or specific mode of exposure to), an appropriate organism. 
